Ovarian cancer that overexpressed Wnt5A also showed lower chemosensitivity to paclitaxel, oxaliplatin, 5-fluorouracil, epirubicin and etoposide [36]. The gene discussed is WNT5A; the disease is ovarian carcinoma.